Robert F. Kennedy, Jr. at a campaign rally on Nov. 1, 2024 (Julia Demaree Nikhinson/AP Images)
December 11, 2024 03:09 PM EST
Pharma
FDA+
Coronavirus

Dur­ing Covid, RFK Jr. lob­bied against vac­cine EUAs for chil­dren. As HHS sec­re­tary, he could re­scind them

Zachary Brennan

Senior Editor

Robert F. Kennedy Jr., Pres­i­dent-elect Don­ald Trump’s choice to lead the De­part­ment of Health and Hu­man Ser­vices, would have the abil­i­ty to quick­ly act on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

The End­points 100: The biotech in­dus­try braces for Trump 2.0

Can­del’s shares soar on Phase 3 prostate can­cer da­ta de­spite un­clear prospects

Eli Lil­ly has tapped tele­health start­up Ro to dis­trib­ute its sin­gle-dose Zep­bound vials

Gene edit­ing com­pa­nies seek safer, less gru­el­ing con­di­tion­ing meth­ods for blood stem cell ther­a­pies

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times